about
sameAs
Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosisInside out: the role of nucleocytoplasmic transport in ALS and FTLDNovel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degenerationAge of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach.Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice.Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR).Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data.Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth DiseaseExome sequencing reveals HINT1 mutations as a cause of distal hereditary motor neuropathySporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 casesProgranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathyModelling amyotrophic lateral sclerosis: progress and possibilitiesIdentification and characterization of Nanobodies targeting the EphA4 receptor.Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationC9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysisPolymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosisVascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation.Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP)Neurological picture. FDG-PET findings in three cases of Mills' syndrome.Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAsBenefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study.Rapamycin increases survival in ALS mice lacking mature lymphocytes.Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis.Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice.Recent advances in motor neuron disease.No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.ATXN2 trinucleotide repeat length correlates with risk of ALS.TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.The neurobiology of amyotrophic lateral sclerosis.Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues.EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD.Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis.Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS).
P50
Q24623830-B5186B38-F655-4EC4-AE21-A470131EB691Q26748482-C408A360-D5E1-4963-977F-AA91D338AF64Q28297622-F864156F-D4D0-45B8-BC9A-6A0BC460F2F8Q29417029-26AC1087-5A45-43CF-8FA3-937724D63AE4Q29417136-BD44F252-21D8-4CE2-9208-C3A5A321717DQ30009313-AA244EBE-1D88-4C82-92FD-2933CB6CAB06Q30583228-0FA035F2-60FA-4CDA-8CD5-98E9809F6696Q30832937-8FD59DBF-2338-48AB-ABEC-23DA2AEF0B60Q31099553-8F590BAA-BF17-4960-84CC-D19CF7DEB0F2Q33586017-98D99D42-5AAA-47EA-827A-1D854AA730BFQ33620795-DDBB46BB-B0D6-48B3-9AA9-01551BC6685BQ33660088-7F93ADA3-2FAE-496B-B384-28BB436CDF61Q33725391-7052A28A-83D1-4799-9525-18CABF5D3054Q33725391-900EF5CE-C9CB-4C58-8AB1-1F2FBAE477D0Q33746289-AD6F8959-8B6B-41BD-AF92-36E3B72A8080Q33882055-5211A175-1C94-4279-B0A8-AAA6CDE94025Q34038343-54A56BD1-79F0-4BC5-9D35-6155A864E193Q34063137-724244B3-6FE3-4EF0-8CCA-59EBF4ACEAFCQ34173712-4859CB4F-F675-45B1-8023-7E7E45786A5AQ34549555-9765B1EA-9557-4BA1-8756-7478A49910ABQ36038732-5298C58A-9431-4E9C-A4C3-E19AF28A97C4Q36257577-7CEA32FC-D171-4D50-9E2F-27AE46412301Q36577258-560A7738-C268-44B4-99D3-5F1E7C917E2BQ36880235-FA5345F1-AC73-4319-91F1-38285CF8FE99Q37206684-0736D701-0AD7-4C1B-8F17-94A6E133233DQ37357775-A419B1BD-FB17-4574-AC0D-EFDC125CD9BAQ37379980-5D22FE9D-420A-4023-BC34-1A355A912E0BQ37528939-192FC038-10A6-4172-B451-F042355F6240Q37547916-F93389FE-FCD6-4819-9A84-7F8CFA6DA21AQ37619291-9FB57621-C839-42F5-981A-BC53C3EF4EC4Q37635857-5CB28E3A-AA9A-4DE7-926E-F061CD51EC87Q37664119-8EB54AAB-8671-4567-8075-E82B9FCA3009Q37763285-E77B9307-9255-4E3D-BDEE-3A3A0DDC9E73Q37798898-FB77466B-0AAB-4474-93F7-A1DCCE8B14BDQ37931374-7617BC7B-DDFF-4AB8-967B-ED9119CDD718Q37970653-E318C216-4B30-4820-BC53-90C5ED3EDC76Q38322311-9240E342-6235-4BAC-BAD1-E7A88528DA40Q38379408-24286F6C-0CC5-4A2B-B3F3-F8DED27C9F43Q38717661-19DB9035-240D-4A85-AB5B-8D4C90584A10Q38779496-2E57F2BB-A3BF-45BB-B892-4D0C6A08E950
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Philip Van Damme
@ast
Philip Van Damme
@en
Philip Van Damme
@es
Philip Van Damme
@nl
Philip Van Damme
@sl
type
label
Philip Van Damme
@ast
Philip Van Damme
@en
Philip Van Damme
@es
Philip Van Damme
@nl
Philip Van Damme
@sl
prefLabel
Philip Van Damme
@ast
Philip Van Damme
@en
Philip Van Damme
@es
Philip Van Damme
@nl
Philip Van Damme
@sl
P106
P108
P21
P214
3051148705704037080005
P2798
P31
P496
0000-0002-4010-2357
P734
P735
P7859
viaf-3051148705704037080005